Correction to: Cost‑Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece.
Gourzoulidis GeorgeMaria KoulentakiAntonis KattamisMaria BouzaniChara GiatraVassiliki ChotzagiannoglouAlexandra BeletsiGeorgia KourlabaPublished in: Clinical drug investigation (2022)